As if being sick weren’t bad enough, there’s also the fear of frequent injections, side effects and overdosing on you medication.
Now a team of researchers from University of Copenhagen, Department of Chemistry, Nano-science center and the Institut Laue-Langevin (ILL), have shown that reservoirs of anti-viral pharmaceuticals could be manufactured to bind specifically to infected tissue such as cancer cells for the slow concentrated delivery of drug treatments. The new research is published in ACS Macro Letters.
Smaller doses, less injections and fewer side effects
The findings, from Dr Marité Cárdenas (Copenhagen) and Dr Richard Campbell and Dr Erik Watkins (ILL), came as a result of neutron reflectometry studies at the world’s leading neutron source in Grenoble, France. They could provide a way to reduce dosages and the frequency of injections administered to patients undergoing a wide variety of treatments, as well as minimising side effects of over-dosing.
Fats and branches hold medicine for longer
The attachment of reservoirs of therapeutic drugs to cell membranes for slow diffusion and continuous delivery inside the cells is a major aim in drug R&D. A promising candidate for packaging up and carrying such concoctions of drugs are a group of self-assembled liquid crystalline particles. Composed of fatty molecules known as phospholipids and tree-like macromolecules called dendrimers which have many branches, the particles form spontaneously and have the capacity to soak up and carry large quantities of drug molecules for prolonged diffusion. They are also known for their ability to bind to cellular membranes.
First treatment close to market
The first treatments using such particles are close to market through products incorporating a similar formulation called Cubosomes (cubic phase nanoparticles). Developed and commercialized by Swedish start-up Camarus Ab, its FluidCrystal® nanoparticles promise months of drug delivery from a single injection and the possibility of tuning the delivery to intervals of anything from daily to once monthly. However, a key requirement for optimal application of these formulations is a detailed understanding of how they interact with cellular membranes.
This was the focus of work involving a collaboration between Dr Marité Cárdenas (Copenhagen) and Dr Richard Campbell and Dr Erik Watkins (ILL). In this experiment the team used neutrons to analyse the interaction of the liquid crystalline particles with a model cellular membrane whilst varying two parameters:
- Gravity – to see how the interaction changed if the aggregates attacked the cell membrane from below as opposed to above
- Electrostatics – how the balance between the contrasting positive and negative charges of the aggregate and membrane affect the interaction
Detailed surface information with bouncing electrons
The team utilised a technique known as neutron reflectometry whereby beams of neutrons are skimmed off a surface and the reflectivity measured is used to infer detailed information about the surface, including the thickness, detailed structure and composition of any layers beneath. These experiments were carried out on the FIGARO instrument at the ILL in Grenoble which offers unique reflection up vs. down modes that allowed the team to examine the top and bottom surfaces, alternating the samples on a two hourly basis during a 30 hour sampling period.
Small changes to charge of molecules could have major effects
The interaction of the liquid crystalline particles with the membrane was shown to be driven by the charge on the mode cell wall. Subtle changes in the amount of negative charge on the membrane wall encouraged the tree-like dendrimer molecules to penetrate through allowing the rest of the molecule to bind to the surface, forming an attached reservoir. The sensitivity of the interaction to small changes in charge suggests that simple adjustments to the proportion of charged lipids and macromolecules could optimise this process. In the future this characteristic could also provide a mechanism to focus the treatment at targeted cells such as those infected by cancer which are thought to have a more negative charge density than healthy cells.
“Cancerous cells have an imbalance that gives them a different molecular composition and overall different physical properties to normal healthy cells”, explains Dr Cardenas. “Whilst all cells are negative, cancerous cells tend to be more negatively charged than healthy ones due to a different composition of fatty molecules on their surface. This is a property that we believe could be exploited in future research into delivery mechanisms involving the attachment of lamellar liquid crystalline particles. Our next step is to introduce the drug itself into the reservoirs and make sure it can move across the membrane. This work paves the way for cell tests and clinical trials in the future exploiting our methodology”
The Latest on: Cancer treatment
via Google News
The Latest on: Cancer treatment
- Clarenville surgeon details new procedure for breast cancer treatmenton December 2, 2019 at 11:26 am
Jonathan Parsons CLARENVILLE, N.L. — General surgeon Dr. Ryno Verster says implementing a new, innovative surgery for breast cancer treatment is something to strive for, offering patients of G.B.
- Reflecting on photos helps young cancer survivors regain confidenceon December 2, 2019 at 11:04 am
Young cancer survivors face unique medical and psychosocial challenges that can hinder their ability to move on mentally and socially, even years after their final treatment. Lingering feelings of ...
- Risk Factors for Opioid Misuse Identified in Cancer Patientson December 2, 2019 at 10:41 am
Can related risk factors be identified? A new study of US military veterans has found that the overall incidence of persistent post-cancer treatment opioid use was 8.3% and was highest in patients who ...
- Financial toxicity associated with treatment of localized prostate canceron December 2, 2019 at 10:39 am
Financial toxicity is a broad term to describe the economic consequences and subjective burden resulting from a cancer diagnosis and treatment. As financial toxicity is associated with poor disease ...
- Scientists discover new principle for activation of cancer geneson December 2, 2019 at 10:37 am
The researchers hope the findings could open up for a new generation of cancer treatments that are less harmful than for example radiation and chemotherapy, which knock out many normally growing cells ...
- Endometriosis could be treated with cancer drug, study suggestson December 2, 2019 at 9:42 am
The painful symptoms of endometriosis—a chronic condition which affects millions of women—could potentially be reduced with a drug that had previously been investigated as a cancer treatment.
- New treatment triggers self-destruction of pancreatic cancer cellson December 2, 2019 at 9:38 am
Pancreatic cancer is resistant to all current treatments. Patients have extremely poor chances of surviving for five years after being diagnosed. A new Tel Aviv University study finds that a small ...
- New Stem Cell Research Could Make Cancer Treatments affordable and Effective for Hospitals and Patientson December 2, 2019 at 9:00 am
Current cancer cell therapies like CAR T Cells cost between $350k (USD) and $500k (USD.) INTELLiSTEM expects its Super Sentinel Cells™ (SSCs) treatment to be priced between $30-$50k USD. This ...
- Real-world Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysison December 2, 2019 at 2:20 am
Treatment patterns and outcomes are unclear for metastatic breast cancer (MBC) patients diagnosed with hormone receptor-positive (HR+), human epidermal growth factor 2-positive (HER2+) disease. This ...
- Novel MRI-Guided Ultrasound Treatment Destroys Prostate Canceron December 2, 2019 at 2:08 am
The trial enrolled 115 men, median age 65, with localized low or intermediate risk, gland-confined prostate cancer. Clinicians delivered TULSA treatment to the entire gland. Treatment time averaged 51 ...
via Bing News